EQS-Adhoc Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025
EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Financing
Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025
By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2.50 and is convertible into registered shares of Vitruvia Medical AG.
The funds will be used to finance existing projects (LT technologies GmbH & Co. KG), acquisitions (rebuilding of the investment portfolio) and general corporate financing.
Anglikon, 26 November 2022
Vitruvia Medical Ltd.
Board of directors
26-Nov-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|Company:||Vitruvia Medical AG|
|Phone:||+41 44 915 33 78|
|Listed:||Regulated Unofficial Market in Munich|
|EQS News ID:||1498163|
|End of Announcement||EQS News Service|
1498163 26-Nov-2022 CET/CEST